Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1969 Jun;55(3):379–393.

Pathogenetic mechanisms in protein-induced amyloidosis.

D T Janigan
PMCID: PMC2013555  PMID: 4182846

Full text

PDF
379

Images in this article

393Fig 1
on p.393
393Fig 2
on p.393
393Fig 3
on p.393
393Fig 4
on p.393

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azar H. A. Amyloidosis and plasma cell disorders. Annu Rev Med. 1966;17:49–62. doi: 10.1146/annurev.me.17.020166.000405. [DOI] [PubMed] [Google Scholar]
  2. Clerici E., Pierpaoli W., Romussi M. Experimental amyloidodis in immunity. Pathol Microbiol (Basel) 1965;28(5):806–815. doi: 10.1159/000161835. [DOI] [PubMed] [Google Scholar]
  3. Cohen A. S. The constitution and genesis of amyloid. Int Rev Exp Pathol. 1965;4:159–243. [PubMed] [Google Scholar]
  4. Druet R. L., Janigan D. T. Experimental amyloidosis. Amyloid induction with a soluble protein antigen in intact, bursectomized and thymectomized chickens. Am J Pathol. 1966 Dec;49(6):1103–1123. [PMC free article] [PubMed] [Google Scholar]
  5. Druet R. L., Janigan D. T. Experimental amyloidosis. Rates of induction, lymphocyte depletion and thymic atrophy. Am J Pathol. 1966 Nov;49(5):911–929. [PMC free article] [PubMed] [Google Scholar]
  6. Hultgren M. K., Druet R. L., Janigan D. T. Experimental amyloidosis in isogeneic x-irradiated recipients of sensitized spleen tissue. Am J Pathol. 1967 Jun;50(6):943–955. [PMC free article] [PubMed] [Google Scholar]
  7. JANIGAN D. T. EXPERIMENTAL AMYLOIDOSIS: STUDIES WITH A MODIFIED CASEIN METHOD, CASEIN HYDROLYSATE AND GELATIN. Am J Pathol. 1965 Jul;47:159–171. [PMC free article] [PubMed] [Google Scholar]
  8. Janigan D. T., Druet R. L. Experimental amyloidosis. Role of antigenicity and rapid induction. Am J Pathol. 1966 Jun;48(6):1013–1025. [PMC free article] [PubMed] [Google Scholar]
  9. Janigan D. T., Druet R. L. Experimental murine amyloidosis in x-irradiated recipients of spleen homogenates or serum from sensitized donors. Am J Pathol. 1968 Feb;52(2):381–390. [PMC free article] [PubMed] [Google Scholar]
  10. Janigan D. T., Druet R. L. The role of the immunologic apparatus in the pathogenesis of experimental amyloidosis. Isr J Med Sci. 1968 Sep-Oct;4(5):1035–1043. [PubMed] [Google Scholar]
  11. Letterer E., Kretschmer R. Experimental amyloidosis and tolerance. Nature. 1966 Apr 23;210(5034):390–391. doi: 10.1038/210390a0. [DOI] [PubMed] [Google Scholar]
  12. Liacopoulos P., Perrament M. F., Binaghi R. Increased IgG synthesis during the induction of immunological paralysis in adult guinea pigs. Nature. 1967 Oct 7;216(5110):81–82. doi: 10.1038/216081a0. [DOI] [PubMed] [Google Scholar]
  13. Ranlov P. Effects of heterospecific antiserum against lymph node cells on the development of experimental amyloidosis in mice. Acta Pathol Microbiol Scand. 1967;69(4):534–542. [PubMed] [Google Scholar]
  14. Ranlov P. The adoptive transfer of experimental mouse amyloidosis by intravenous injections of spleen cell extracts from casein-treated syngeneic donor mice. Acta Pathol Microbiol Scand. 1967;70(3):321–335. [PubMed] [Google Scholar]
  15. TEILUM G. PATHOGENESIS OF AMYLOIDOSIS. Acta Pathol Microbiol Scand. 1964;61:21–45. doi: 10.1111/apm.1964.61.1.21. [DOI] [PubMed] [Google Scholar]
  16. Werdelin O., Ranlov P. Amyloidosis in mice produced by transplantation of spleen cells from casein-treated mice. Acta Pathol Microbiol Scand. 1966;68(1):1–18. doi: 10.1111/apm.1966.68.1.1. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES